To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
19 Current news of GlobalData
rss
Pfizer contemplates $2 billion acquisition of Strides’ Agila Unit
22-01-2013
As drug makers continue to jostle for market share and deal with declining revenues from their off-patent blockbuster drugs, M&A activity is showing no indication of slowing down in 2013. Pfizer is not leaving any stone unturned as the company continues its growth. Less than two months after ...
H1N1 pandemic fears to maintain lofty US flu vaccination levels
11-01-2013
US demand for influenza vaccines will remain high in the coming decade, following a post-flu pandemic spike, predicts business intelligence provider GlobalData. According to the company’s latest epidemiology report, seasonal influenza vaccine demand will increase from the 142 million expected ...
Biotech Strategy Evolves in Big Pharma’s Footsteps
26-11-2012
Biotech companies are exploring alternative options to supplement their in-house research and development (R&D), abandoning the traditional blockbuster drug model to instead pursue deals and buy their way to success, says healthcare intelligence providers GlobalData in a new report, which ...
Analyst Insight: Rapid Detection of Pandemics: Identifying the Unknown
10-10-2012
A Severe Acute Respiratory Syndrome (SARS)-like coronavirus is back in the headlines. A Qatari national, recently returned from a trip to Saudi Arabia, was struck down by a mystery respiratory illness. A lack of diagnostic capability led to the patient being transferred from Qatar to London ...
Mexico is Potential Pharma Exporter
22-08-2012
The Mexican healthcare industry needs to readjust for the changing demographics of its citizens, states a new report by healthcare experts GlobalData.The new report, Healthcare, Regulatory and Reimbursement Landscape - Mexico, states that with a population of approximately 112 million, Mexico ...
The World’s First (Official) Biosimilar Antibody Goes to… Rheumatoid Arthritis
10-08-2012
The end of July 2012 proved exciting for the world of biosimilar manufacturers, according to GlobalData. However, for the regulatory officials worldwide it meant more uncertainty and unknowns about proper, global biosimilar guidelines. On July 23, 2012, South Korean biosimilar manufacturer ...
Developing Countries and Generic Drug Firms Shaking Up the Pharma Industry
27-07-2012
Constricted budgets, the ‘patent cliff’ and the rise of emerging economies are forcing pharmaceutical companies to seriously reassess business strategies, finds a new report by healthcare industry analyst firm GlobalData. According to GlobalData’s 2012 Pharmaceutical Benchmark Report, the ...
Spain’s Universal Healthcare Market to Grow despite Struggling Economy
25-07-2012
Spain’s commitment to free universal healthcare means that its pharmaceutical market will continue to grow in the face of continuing economic woes, states a report by business intelligence providers GlobalData. The new research predicts that the Spanish pharmaceutical market will rise from a ...
Russia’s Pharma Industry Impresses as Economy Continues to Grow
29-06-2012
The Russian pharmaceutical industry will continue to expand due to government initiatives and increased healthcare spending, predicts a new report by healthcare business specialists GlobalData.The report, "Healthcare, Regulatory and Reimbursement Landscape - Russia", states that Russia’s ...
MEK Inhibitors: A New Weapon in the Fight Against Melanoma
25-06-2012
Cancer cell signaling has long been an attractive target for oncology drug development. Increased activation of cell survival signaling cascades promotes tumor cell growth and makes cancer cells difficult to kill. Inhibiting proteins that are involved in these survival pathways is one ...
Netmeeting
